Pierre Sesques
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 43
- CAR-T cell therapy research 36
-
- Lymphoma Diagnosis and Treatment 29
- Co-authors
- Nathalie A. Johnson (1 shared paper)Emmanuel Bachy (20 shared papers)Kai Rejeski (5 shared papers)Michael David Jain (4 shared papers)Gilles Salles (13 shared papers)Frederick Lundry Locke (4 shared papers)Yi Lin (3 shared papers)Marion S. Subklewe (2 shared papers)
- Journals
- Blood (12 papers)Blood Advances (10 papers)Hematological Oncology (8 papers)Journal of Hematology & Oncology (3 papers)American Journal of Hematology (3 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Pierre Sesques
63 papers receiving 2.2k citations
Pierre Sesques's Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 1.7k
- Pathology and Forensic Medicine 689
- Genetics 252
- Immunology 271
- Hematology 144
Countries citing papers authored by Pierre Sesques
This map shows the geographic impact of Pierre Sesques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Sesques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Sesques more than expected).
Fields of papers citing papers by Pierre Sesques
This network shows the impact of papers produced by Pierre Sesques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Sesques. The network helps show where Pierre Sesques may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Sesques, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma Hit paper breakdown → | 2021 | 358 |
| 2 | A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma Hit paper breakdown → | 2022 | 299 |
| 3 | 2015 | 191 | |
| 4 | 2016 | 126 | |
| 5 | 2020 | 115 | |
| 6 | 2022 | 115 | |
| 7 | 2023 | 99 | |
| 8 | 2021 | 95 | |
| 9 | 2021 | 81 | |
| 10 | 2023 | 59 | |
| 11 | 2021 | 51 | |
| 12 | 2022 | 51 | |
| 13 | 2015 | 49 | |
| 14 | 2021 | 43 | |
| 15 | 2023 | 41 | |
| 16 | 2021 | 39 | |
| 17 | 2020 | 37 | |
| 18 | 2022 | 30 | |
| 19 | 2018 | 27 | |
| 20 | 2024 | 24 |
About Pierre Sesques
Pierre Sesques is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Immunology and Neurology, having authored 69 papers that have together received 2.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (36 papers), Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (11 papers), Virus-based gene therapy research (10 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Silicon Carbide Semiconductor Technologies (6 papers), Integrated Circuits and Semiconductor Failure Analysis (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). The work is most often cited by research in Oncology (1.7k citations), Pathology and Forensic Medicine (689 citations), Genetics (252 citations), Immunology (271 citations) and Hematology (144 citations). Pierre Sesques has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Nathalie A. Johnson, Emmanuel Bachy, Kai Rejeski, Michael David Jain, Gilles Salles, Frederick Lundry Locke, Yi Lin, Marion S. Subklewe, Yucai Wang and Melissa Alsina. Their work appears in journals such as Blood, Blood Advances, Hematological Oncology, Journal of Hematology & Oncology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.